A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology
Larisa G. Tereshchenko(Cleveland Clinic Lerner College of Medicine), Rod S Taylor(University of Southern Denmark), Anthony Muchai Manyara(University of Bristol), Sanjiv M. Narayan(Palo Alto University), José F. Huizar(Virginia Commonwealth University), Pasquale Santangeli(Cleveland Clinic), Marmar Vaseghi(University of California, Los Angeles), Stephen Sodeke(Tuskegee University), Mina K. Chung(Cleveland Clinic), Chastity Bradford(Tuskegee University), Oussama Wazni(Cleveland Clinic), Kenneth A. Ellenbogen(Virginia Commonwealth University), Samir R Kapadia(Cleveland Clinic), Sumeet S. Chugh(Cedars-Sinai Medical Center), Kenneth Bilchick(University of Virginia), Oriana Ciani(Bocconi University)
Cited by 1
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Worldwide Epidemiology of Atrial Fibrillation
|Circulation|2013|4.5k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k